Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis

IF 6.8 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Clinical and Translational Medicine Pub Date : 2025-02-09 DOI:10.1002/ctm2.70202
Shuoyi Ma, Erzhuo Xia, Miao Zhang, Yinan Hu, Siyuan Tian, Xiaohong Zheng, Bo Li, Gang Ma, Rui Su, Keshuai Sun, Qingling Fan, Fangfang Yang, Guanya Guo, Changcun Guo, Yulong Shang, Xinmin Zhou, Xia Zhou, Jingbo Wang, Ying Han
{"title":"Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis","authors":"Shuoyi Ma,&nbsp;Erzhuo Xia,&nbsp;Miao Zhang,&nbsp;Yinan Hu,&nbsp;Siyuan Tian,&nbsp;Xiaohong Zheng,&nbsp;Bo Li,&nbsp;Gang Ma,&nbsp;Rui Su,&nbsp;Keshuai Sun,&nbsp;Qingling Fan,&nbsp;Fangfang Yang,&nbsp;Guanya Guo,&nbsp;Changcun Guo,&nbsp;Yulong Shang,&nbsp;Xinmin Zhou,&nbsp;Xia Zhou,&nbsp;Jingbo Wang,&nbsp;Ying Han","doi":"10.1002/ctm2.70202","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background/aims</h3>\n \n <p>The molecular mechanisms driving nonalcoholic steatohepatitis (NASH) progression are poorly understood. This research examines the involvement of chaperone-mediated autophagy (CMA) in NASH progression.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Hepatic CMA activity was analysed in NASH mice and patients. Lysosome-associated membrane protein 2A (LAMP2A) was knocked down or overexpressed to assess the effects of hepatocyte-specific CMA on NASH progression. Mice received a high-fat diet or a methionine and choline-deficient diet to induce NASH. Palmitic acid was employed to mimic lipotoxicity-induced hepatocyte damage in vitro. The promoter activity of FOXM1 was evaluated via ChIP and dual-luciferase reporter assays.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Hepatic CMA activity was substantially low in NASH mice and patients. LAMP2A knockdown resulted in hepatocyte-specific CMA deficiency, which promoted fibrosis and hepatic inflammation in NASH mice. Both in vitro and in vivo, CMA deficiency also exacerbated hepatocyte damage and endoplasmic reticulum (ER) stress. Mechanistically, CMA deficiency in hepatocytes increased cholesterol accumulation by blocking the degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCR), a key cholesterol synthesis-related enzyme, and the accumulated cholesterol subsequently induced ER stress and hepatocyte damage. The restoration of hepatocyte-specific CMA activity effectively ameliorated diet-induced NASH and ER stress in vivo and in vitro. FOXM1 directly bound to LAMP2A promoter and negatively regulated its transcription. The upregulation of FOXM1 expression impaired CMA and enhanced ER stress, which in turn increased FOXM1 expression, resulting in a vicious cycle and promoting NASH development.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This study highlights the significance of the FOXM1/CMA/ER stress axis in NASH progression and proposes novel therapeutic targets for NASH.</p>\n </section>\n \n <section>\n \n <h3> Key points</h3>\n \n <div>\n <ul>\n \n <li>Chaperone-mediated autophagy (CMA) deficiency in hepatocytes promotes hepatic inflammation and fibrosis in mice with nonalcoholic steatohepatitis (NASH) by inducing cholesterol accumulation and endoplasmic reticulum (ER) stress.</li>\n \n <li>Upregulated FOXM1 impairs CMA by suppressing the transcription of lysosome-associated membrane protein 2A (LAMP2A), a rate-limiting component of CMA.</li>\n \n <li>ER stress increases FOXM1 expression and cholesterol accumulation.</li>\n \n <li>FOXM1/CMA/ER stress axis forms a vicious circle and promotes the development of NASH.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 2","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70202","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70202","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aims

The molecular mechanisms driving nonalcoholic steatohepatitis (NASH) progression are poorly understood. This research examines the involvement of chaperone-mediated autophagy (CMA) in NASH progression.

Methods

Hepatic CMA activity was analysed in NASH mice and patients. Lysosome-associated membrane protein 2A (LAMP2A) was knocked down or overexpressed to assess the effects of hepatocyte-specific CMA on NASH progression. Mice received a high-fat diet or a methionine and choline-deficient diet to induce NASH. Palmitic acid was employed to mimic lipotoxicity-induced hepatocyte damage in vitro. The promoter activity of FOXM1 was evaluated via ChIP and dual-luciferase reporter assays.

Results

Hepatic CMA activity was substantially low in NASH mice and patients. LAMP2A knockdown resulted in hepatocyte-specific CMA deficiency, which promoted fibrosis and hepatic inflammation in NASH mice. Both in vitro and in vivo, CMA deficiency also exacerbated hepatocyte damage and endoplasmic reticulum (ER) stress. Mechanistically, CMA deficiency in hepatocytes increased cholesterol accumulation by blocking the degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCR), a key cholesterol synthesis-related enzyme, and the accumulated cholesterol subsequently induced ER stress and hepatocyte damage. The restoration of hepatocyte-specific CMA activity effectively ameliorated diet-induced NASH and ER stress in vivo and in vitro. FOXM1 directly bound to LAMP2A promoter and negatively regulated its transcription. The upregulation of FOXM1 expression impaired CMA and enhanced ER stress, which in turn increased FOXM1 expression, resulting in a vicious cycle and promoting NASH development.

Conclusions

This study highlights the significance of the FOXM1/CMA/ER stress axis in NASH progression and proposes novel therapeutic targets for NASH.

Key points

  • Chaperone-mediated autophagy (CMA) deficiency in hepatocytes promotes hepatic inflammation and fibrosis in mice with nonalcoholic steatohepatitis (NASH) by inducing cholesterol accumulation and endoplasmic reticulum (ER) stress.
  • Upregulated FOXM1 impairs CMA by suppressing the transcription of lysosome-associated membrane protein 2A (LAMP2A), a rate-limiting component of CMA.
  • ER stress increases FOXM1 expression and cholesterol accumulation.
  • FOXM1/CMA/ER stress axis forms a vicious circle and promotes the development of NASH.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
FOXM1/CMA/ER应激轴在调节非酒精性脂肪性肝炎进展中的作用
背景/目的非酒精性脂肪性肝炎(NASH)进展的分子机制尚不清楚。本研究探讨了伴侣介导的自噬(CMA)在NASH进展中的作用。方法对NASH小鼠和患者肝脏CMA活性进行分析。溶酶体相关膜蛋白2A (LAMP2A)被敲低或过表达,以评估肝细胞特异性CMA对NASH进展的影响。小鼠接受高脂肪饮食或蛋氨酸和胆碱缺乏饮食诱导NASH。采用棕榈酸模拟体外脂毒诱导的肝细胞损伤。FOXM1启动子活性通过ChIP和双荧光素酶报告基因检测进行评估。结果NASH小鼠和患者肝脏CMA活性明显降低。LAMP2A敲低导致肝细胞特异性CMA缺失,从而促进NASH小鼠的纤维化和肝脏炎症。在体内和体外,CMA缺乏还会加重肝细胞损伤和内质网应激。机制上,肝细胞CMA缺乏通过阻断3-羟基-3-甲基戊二酰辅酶A(一种关键的胆固醇合成相关酶)的降解而增加胆固醇积累,积累的胆固醇随后诱导内质网应激和肝细胞损伤。肝细胞特异性CMA活性的恢复在体内和体外有效改善饮食诱导的NASH和内质网应激。FOXM1直接结合到LAMP2A启动子上,负向调控其转录。FOXM1表达上调,CMA受损,内质网应激增强,内质网应激又增加FOXM1表达,形成恶性循环,促进NASH发展。本研究强调了FOXM1/CMA/ER应激轴在NASH进展中的重要性,并提出了新的NASH治疗靶点。肝细胞伴侣介导的自噬(CMA)缺乏通过诱导胆固醇积累和内质网(ER)应激,促进非酒精性脂肪性肝炎(NASH)小鼠的肝脏炎症和纤维化。上调的FOXM1通过抑制溶酶体相关膜蛋白2A (lam2a)的转录来损害CMA, lam2a是CMA的限速成分。内质网应激增加FOXM1表达和胆固醇积累。FOXM1/CMA/ER应力轴形成恶性循环,促进NASH的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
文献相关原料
公司名称
产品信息
索莱宝
Serum Transaminase Kit
索莱宝
Micro FC Content Assay Kit
来源期刊
CiteScore
15.90
自引率
1.90%
发文量
450
审稿时长
4 weeks
期刊介绍: Clinical and Translational Medicine (CTM) is an international, peer-reviewed, open-access journal dedicated to accelerating the translation of preclinical research into clinical applications and fostering communication between basic and clinical scientists. It highlights the clinical potential and application of various fields including biotechnologies, biomaterials, bioengineering, biomarkers, molecular medicine, omics science, bioinformatics, immunology, molecular imaging, drug discovery, regulation, and health policy. With a focus on the bench-to-bedside approach, CTM prioritizes studies and clinical observations that generate hypotheses relevant to patients and diseases, guiding investigations in cellular and molecular medicine. The journal encourages submissions from clinicians, researchers, policymakers, and industry professionals.
期刊最新文献
P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis. Revolutionising acute aortic syndrome diagnosis: The role of artificial intelligence in non-contrast computed tomography Two pathogens, one disease: Rethinking leprosy diversification through ancient and modern genomes The insider's perspective: The intracellular complosome and immune cell dynamics in cancer Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1